Exoskeleton therapy could help improve mobility, cognition and brain connectivity in people with multiple sclerosis (MS), a team of MS experts at Kessler Foundation suggests, in Multiple Sclerosis and Related Disorders.
The researchers conducted a pilot randomized controlled trial of robotic-exoskeleton assisted exercise rehabilitation (REAER) effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability. Results from the trial suggest that REAER is likely an effective intervention, and is a promising therapy for improving the lives of those with MS, according to a media release from Kessler Foundation.
It is common for people with MS to experience impairments in both mobility and cognition, and few therapies exist to manage the range of debilitating symptoms. This lack of treatment options is a major problem for people with MS, especially those with substantial MS-related neurological disability.
Previous research shows that exercise rehabilitation, such as walking, is an effective approach to symptom management, with some research suggesting that even a single exercise rehabilitation intervention can improve both mobility and cognition.
Yet there is a lack of efficacy of exercise rehabilitation on mobility and cognitive outcomes in people with MS who have substantial disability. Adaptive exercise rehabilitation approaches such as body-weight supported treadmill training and robot-assisted gait training have not demonstrated convincing results. Moreover, adaptive interventions lack key interactions between patients and therapists that may improve efficacy, the release continues.
Robotic Exoskeleton to Manage Symptoms
In this pilot study of 10 participants with significant MS-related neurological disability, researchers explored the use of robotic exoskeletons to manage symptoms using an Ekso NR exoskeleton.
As compared to conventional gait training, REAER allows participants to walk at volumes needed to realize functional adaptations — via vigorous neurophysiological demands — that lead to improved cognition and mobility. Effects on brain activity patterns were studied using the functional MRI capabilities of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation.
Investigators compared participants’ improvement after 4 weeks of REAER vs 4 weeks of conventional gait training, looking at functional mobility, walking endurance, cognitive processing speed, and brain connectivity.
Positive Results
The results were positive: Relative to conventional gait training, 4 weeks of REAER was associated with large improvements in functional mobility (?p2=.38), cognitive processing speed (?p2=.53), and brain connectivity outcomes, most significantly between the thalamus and ventromedial prefrontal cortex (?p2=.72).
“Four weeks is relatively short for an exercise training study. Seeing improvements within this time frame shows the potential for exercise to change how we treat MS. Exercise is really powerful behavior that involves many brain regions and networks that can improve over time and result in improved function.”
— Brian M. Sandroff, senior research scientist at Kessler Foundation and director of the Exercise Neurorehabilitation Research Laboratory
“This is particularly exciting because therapy using robotic exoskeletons shows such promise for improving the lives of people with co-occurring mobility and cognitive disability, a cohort that likely has the greatest potential to benefit from this new technology. We’re eager to design a larger trial to further study these effects. Based on our initial results, we’re optimistic that this approach may be superior to the current standard of care.”
— Ghaith J. Androwis, lead author and research scientist in the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation
[Source(s): Kessler Foundation, Science Daily]
Related Content:
Multiple Sclerosis and Occupational Therapy: How it Works
MedRhythms and Massachusetts General Hospital Launch Study of Gait Asset for Multiple Sclerosis
Could Rising Temperatures Have This Effect on Multiple Sclerosis Patients?
